share_log

HC Wainwright & Co. Maintains Buy on BioNTech, Raises Price Target to $113

HC Wainwright & Co. Maintains Buy on BioNTech, Raises Price Target to $113

HC Wainwright & Co.维持对BioNTech的买入,将目标股价上调至113美元
Benzinga ·  05/08 07:20

HC Wainwright & Co. analyst Robert Burns maintains BioNTech (NASDAQ:BNTX) with a Buy and raises the price target from $107 to $113.

HC Wainwright & Co. 分析师罗伯特·伯恩斯维持BioNTech(纳斯达克股票代码:BNTX)的买入并将目标股价从107美元上调至113美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发